Skip to main content
. 2024 May 16;7(5):e2411726. doi: 10.1001/jamanetworkopen.2024.11726

Figure 3. Event-Free Survival According to Race and Cytarabine Pharmacogenomic 10–Single-Nucleotide Variant (ACS10) Score for Patients Treated With Augmented Induction Therapy.

Figure 3.